GrandeDA, SoutherlandSS, ManjiR, PateDW, SchwartzSE and LucasPA. (1995). Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng, 1:345–353.
2.
HaynesworthSE, GoshimaJ, GoldbergVM and CaplanAI. (1992). Characterization of cells with osteogenic potential from human marrow. Bone, 13:81–88.
3.
TomaC, PittengerMF, CahillKS, ByrneBJ and KesslerPD. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105:93–98.
4.
YoungRG, ButlerDL, WeberW, GordonSL and FinkDJ. (1997). Mesenchymal stem cell-based repair of rabbit Achilles tendon. Trans Orthop Res Soc, 22:249.
5.
RingdenO, UzunelM, RasmussonI, RembergerM, SundbergB, LonniesH, MarschallHU, DlugoszA, SzakosA, HassanZ, OmazicB, AschanJ, BarkholtL and Le BlancK. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81:1390–1397.
6.
RingdenO, UzunelM, SundbergB, LonniesL, NavaS, GustafssonJ, HenningsohnL and Le BlancK. (2007). Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia, 21:2271–2276.
7.
HaynesworthSE, BaberMA and CaplanAI. (1996). Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol, 166:585–592.
8.
MajumdarMK, ThiedeMA, MoscaJD, MoormanM and GersonSL. (1998). Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol, 176:57–66.
9.
ChengL, QasbaP, VanguriP and ThiedeMA. (2000). Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. J Cell Physiol, 184:58–69.
10.
MbalavieleG, JaiswalN, MengA, ChengL, Van Den BosC and ThiedeM. (1999). Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology, 140:3736–3743.
11.
PittengerMF, MackayAM, BeckSC, JaiswalRK, DouglasR, MoscaJD, MoormanMA, SimonettiDW, CraigS and MarshakDR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284:143–147.
12.
Almeida-PoradaG, FlakeAW, GlimpHA and ZanjaniED. (1999). Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol, 27:1569–1575.
13.
AnkerPS, NoortWA, KruisselbrinkAB, ScherjonSA, BeekhuizenW, WillemzeR, KanhaiHH and FibbeWE. (2003). Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol, 31:881–889.
14.
MaitraB, SzekelyE, GjiniK, LaughlinMJ, DennisJ, HaynesworthSE and KocON. (2004). Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant, 33:597–604.
15.
KocON, GersonSL, CooperBW, DyhouseSM, HaynesworthSE, CaplanAI and LazarusHM. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol, 18:307–316.
16.
BallLM, BernardoME, RoelofsH, LankesterA, CometaA, EgelerRM, LocatelliF and FibbeWE. (2007). Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110:2764–2767.
17.
LazarusHM, KocON, DevineSM, CurtinP, MaziarzRT, HollandHK, ShpallEJ, McCarthyP, AtkinsonK, CooperBW, GersonSL, LaughlinMJ, LoberizaFRJr., MoseleyAB and BacigalupoA. (2005). Cotransplantation of HLA-identical sibling culture expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 11:389–398.
18.
Le BlancK, SamuelssonH, GustafssonB, RembergerM, SundbergB, ArvidsonJ, LjungmanP, LonniesH, NavaS and RingdenO. (2007). Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia, 21:1733–1738.
19.
MacmillanML, BlazarBR, DeForTE and WagnerJE. (2009). Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial. Bone Marrow Transplant, 43:447–454.
20.
Le BlancK and RingdenO. (2005). Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 11:321–334.
21.
MattssonJ, RingdenO and StorbR. (2008). Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant, 14:165–170.
22.
DregerP, SuttorpM, HaferlachT, LofflerH, SchmitzN and SchroyensW. (1993). Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood, 81:1404–1407.
23.
LaroccaA, PiaggioG, PodestaM, PittoA, BrunoB, Di GraziaC, GualandiF, OcchiniD, RaiolaAM, DominiettoA, BreganteS, LamparelliT, TedoneE, OnetoR, FrassoniF, Van LintMT, PoglianiE and BacigalupoA. (2006). Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica, 91:935–940.
24.
MeulemanN, TondreauT, AhmadI, KwanJ, CrokaertF, DelforgeA, DorvalC, MartiatP, LewalleP, LagneauxL, and BronD. (2009). Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev, 10:xxxx–xxxx.
25.
KarlssonH, SamarasingheS, BallLM, SundbergB, LankesterAC, DazziF, UzunelM, RaoK, VeysP, Le BlancK, RingdenO and AmroliaPJ. (2008). Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood, 112:532–541.
26.
RingdenO, LabopinM, GorinNC, Le BlancK, RochaV, GluckmanE, ReiffersJ, ArceseW, VossenJM, JouetJP, CordonnierC and FrassoniF. (2004). Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol, 22:416–423.
27.
ShimodaK, OkamuraS, InabaS, OkamuraT, OhgaS, UedaK and NihoY. (1993). Granulocyte colony-stimulating factor and platelet aggregation. Lancet, 341:633.
28.
SvahnBM, AlvinO, RingdenO, GardulfA and RembergerM. (2006). Costs of allogeneic hematopoietic stem cell transplantation. Transplantation, 82:147–153.
